Blog
About

5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Treatment options for C3 glomerulopathy.

      Current Opinion in Nephrology and Hypertension

      Adolescent, Young Adult, Treatment Outcome, pathology, immunology, drug effects, Kidney, therapeutic use, adverse effects, Immunosuppressive Agents, Humans, drug therapy, diagnosis, Glomerulonephritis, Membranoproliferative, Female, Complement Pathway, Alternative, metabolism, Complement C3, Complement Activation, Animals, Adult

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The purpose of this review is to discuss emerging nomenclature, review the salient clinicopathological features and describe the therapeutic options available for the treatment of C3 glomerulopathy (C3G). C3G is minimally responsive to traditional immune suppression and randomized controlled trials to support therapy are absent. The burgeoning understanding of the role of the alternative complement pathway in C3G combined with animal data supporting the use of terminal complement blockade and a few reports suggesting that the anticomplement drug eculizumab may offer a therapeutic advantage have triggered great interest in the field of complement-mediated renal disease. Anticellular immune suppression and plasma therapy have limited efficacy in C3G. Data suggest that eculizumab may ameliorate disease in some C3G patients. The limited, recently published cohort data highlight crucial aspects of this group of diseases and support the need for extensive genetic and biomarker research to validate the pathologic mechanisms, delineate the spectrum of disease and guide the design of the rigorous trials to identify effective therapies for the treatment of C3G.

          Related collections

          Author and article information

          Journal
          23318699
          10.1097/MNH.0b013e32835da24c
          4437761

          Comments

          Comment on this article